(Q33217629)

24 July 2017

title

Selection of CMV-specific CD8+ and CD4+ T cells by mini-EBV-transformed B cell lines (English)

1 reference

24 July 2017

Andreas Moosmann

9

0 references

Florian Kern

object named as

Florian Kern

5

0 references

Mark Cobbold

4

object named as

Mark Cobbold

1 reference

24 July 2017

Martina Wiesner

1

1 reference

24 July 2017

Caroline Zentz

2

1 reference

24 July 2017

Markus H Hammer

3

1 reference

24 July 2017

Hans-Jochem Kolb

6

1 reference

24 July 2017

Wolfgang Hammerschmidt

7

1 reference

24 July 2017

Reinhard Zeidler

8

1 reference

24 July 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

24 July 2017

number of pages

12

1 reference

European Journal of Immunology

inferred from page(s)

published in

1 reference

24 July 2017

volume

35

1 reference

24 July 2017

issue

7

1 reference

24 July 2017

page(s)

2110-2121

1 reference

Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425936

7 January 2021

Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425936

7 January 2021

Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425936

7 January 2021

Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425936

7 January 2021

Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425936

7 January 2021

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425936

7 January 2021

Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425936

7 January 2021

Adenovirally transduced dendritic cells induce bispecific cytotoxic T lymphocyte responses against adenovirus and cytomegalovirus pp65 or against adenovirus and Epstein-Barr virus EBNA3C protein: a novel approach for immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425936

7 January 2021

Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425936

7 January 2021

Induction of cytomegalovirus (CMV)-specific T-cell responses using dendritic cells pulsed with CMV antigen: a novel culture system free of live CMV virions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425936

7 January 2021

Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425936

7 January 2021

Identification of novel CTL epitopes of CMV-pp65 presented by a variety of HLA alleles

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425936

7 January 2021

Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425936

7 January 2021

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425936

7 January 2021

Characterization of CD4(+) CTLs ex vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425936

7 January 2021

Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425936

7 January 2021

Three T-cell epitopes within the C-terminal 265 amino acids of the matrix protein pp65 of human cytomegalovirus recognized by human lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425936

7 January 2021

Identification of new Th peptides from the cytomegalovirus protein pp65 to design a peptide library for generation of CD4 T cell lines for cellular immunoreconstitution.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425936

7 January 2021

A first-generation packaging cell line for Epstein-Barr virus-derived vectors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425936

7 January 2021

Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425936

7 January 2021

Endogenous MHC class II processing of a viral nuclear antigen after autophagy.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425936

7 January 2021

Fas ligation induces apoptosis of CD40-activated human B lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425936

7 January 2021

Comparative analysis of CD8+ T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425936

7 January 2021

Progress made towards the development of a CMV peptide vaccine.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425936

7 January 2021

Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425936

7 January 2021

Identifiers

DOI

10.1002/EJI.200425936

1 reference

24 July 2017

1 reference